BRD4 and breast cancer: In addition, it has recently been found that the combination of nimbolide, a covalent ligand of RNF114, with BRD4 inhibitor JQ1 to produce PROTAC 8 (Table 1), which targets BRD4, reduced BRD4 expression levels in 231MFP breast cancer cells [41].